by Clinical Neuropsychologist Online | Monday, February 3, 2025 | Neuroscience
Psychology & Neuroscience, Vol 18(1), Mar 2025, 60-75; doi:10.1037/pne0000340Objective: Cultural factors may influence the applicability of performance validity tests (PVTs) in neuropsychological assessment. This study aimed to validate multiple PVTs...
by Clinical Neuropsychologist Online | Monday, February 3, 2025 | Neuroscience
Psychology & Neuroscience, Vol 18(1), Mar 2025, 40-59; doi:10.1037/pne0000354Objective: The great mystery of music is the unique manner in which it is able to convey emotion. Its most domain-specific mechanism for doing so is tonality, most notably scale...
by Clinical Neuropsychologist Online | Saturday, February 1, 2025 | Neuro Podcasts
Today we give you our conversation with Dr. Andrew Kiselica about neuropsychological test interpretation. Andrew is a board-certified clinical neuropsychologist and Associate Professor in the Institute of Gerontology at the University of Georgia. He recently first...
by Clinical Neuropsychologist Online | Friday, January 31, 2025 | Neurorehabilitation
Neurorehabilitation and Neural Repair, Volume 39, Issue 3, Page NP1-NP206, March 2025. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | January 31, 2025...
by Clinical Neuropsychologist Online | Thursday, January 30, 2025 | Dementia
Abstract INTRODUCTION The phase 3 trial CLARITY AD found lecanemab slowed cognitive decline by 27%. However, subgroup analyses indicated a significant 31% sex difference in the effect and suggested no or limited effectiveness in females. We used simulations...
